Cordlife Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Cordlife Group heeft een totaal eigen vermogen van SGD123.0M en een totale schuld van SGD0.0, wat de schuld-eigenvermogensverhouding op 0% brengt. De totale activa en totale passiva bedragen respectievelijk SGD224.3M en SGD101.3M.

Belangrijke informatie

Verhouding schuld/eigen vermogen

S$0

Schuld

Rente dekkingsratio	n/a
Contant	S$59.54m
Aandelen	S$123.03m
Totaal verplichtingen	S$101.27m
Totaal activa	S$224.31m

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

May 06

Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

Mar 22

Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

Sep 07

Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

Aug 02

Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Apr 03

Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Oct 15

Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Aug 22

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( SGD100.5M ) P8A } overtreffen de korte termijn passiva ( SGD32.7M ).

Langlopende schulden: De kortetermijnactiva P8A ( SGD100.5M ) overtreffen de langetermijnschulden ( SGD68.6M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: P8A is schuldenvrij.

Schuld verminderen: P8A heeft geen schulden vergeleken met 5 jaar geleden, toen de schuld/eigen vermogen-ratio 3.8% was.

Schuldendekking: P8A heeft geen schulden en hoeft daarom niet gedekt te worden door de operationele kasstroom.

Rentedekking: P8A heeft geen schulden, dus de dekking van rentebetalingen is geen probleem.

Cordlife Group Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Cordlife Group Limited Appoints Gao Xiang as Independent Non-Executive Director, Effective 14 November 2024 and Chairman of Audit and Risk Committee, Effective 30 November 2024

Cordlife Group Limited Announces Change of Joint Company Secretaries

Cordlife Group Limited Announces Cessation of Tan Huiying as Group Director, Quality and Operations, Effective 4 November 2024

Cordlife Group Limited Announces Re-Designation of Chen Xiaoling from Non-Independent Non-Executive Director to Group Executive Director

High number of new and inexperienced directors

Cordlife Group Limited Announces Changes to the Composition of Board and the Board Composition

Cordlife Group Limited Announces Retirement of Cheong Tuck Yan Titus Jim as Independent Director

Cordlife Group Limited Announces the Appointment of Dato' Dr. Teo Tong Kooi as Independent Non-Executive Director, Effective May 14, 2024

Cordlife Group Limited Announces Directors Removal

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Cordlife Group Limited Announces Board Changes

Cordlife Group Limited Announces Board Resignations

New minor risk - Share price stability

Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.

Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.

Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

New minor risk - Financial data availability

Full year 2023 earnings released: EPS: S$0.015 (vs S$0.019 in FY 2022)

Cordlife Group Limited Announces Changes in the Composition of the Board and Board Committees

New minor risk - Financial data availability

Cordlife Group Limited Announces the Cessation of Tan Poh Lan as Executive Director

Now 34% undervalued after recent price drop

Cordlife Group Limited Announces Resignation of Ms. Tan Poh Lan as a Group Chief Executive Officer, Effective 31 March 2024

Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

New minor risk - Earnings quality

First half 2023 earnings released: EPS: S$0.009 (vs S$0.007 in 1H 2022)

Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

New minor risk - Market cap size

Cordlife Group Limited Announces Change of Company Secretary

Cordlife Group Limited Announces Resignation of Kuan Yoke Kay as the Joint Company Secretary

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Now 20% undervalued after recent price drop

Cordlife Group Limited Appoints that Hnin Yi as Group Chief Financial Officer

Now 20% undervalued after recent price drop

Now 28% undervalued after recent price drop

High number of new directors

Cordlife Group Limited to Report Q1, 2023 Results on Nov 24, 2022

Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Cordlife Group Limited Announces Resignation of Choo Boon Yong as Group Chief Financial Officer

High number of new directors

Cordlife Group Limited Approves Final Tax Exempt (1-Tier) Dividend for the Financial Year Ended 31 December 2021

High number of new directors

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Cordlife Group Limited Proposes Final Tax Exempt Dividend for the Year Ended December 31, 2021, Payable on May 27, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Cordlife Group Limited Appoints Kuan Yoke Kay as the Joint Company Secretary

High number of new directors

Non-Independent Non-Executive Director Lin Wang has left the company

Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Cordlife Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2020, Payable on 28 May 2021

Cordlife Group Limited Announces the Launch of OptiQ

Global Cord Blood Corporation (NYSE:CO) cancelled the acquisition of Cordlife Group Limited (SGX:P8A) in a reverse merger transaction.

New 90-day high: S$0.40

Cordlife Group Limited Announces Resignation of Goh Jin Hian from the Position of Independent Director

First half earnings released

New 90-day high - S$0.40

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven